The Cooper Companies Inc

The Cooper Companies Inc. is a prominent American medical device company specializing in the fields of ophthalmology and fertility. Founded in 1958 by Martin Cooper under the name Cooper Laboratories, the company initially focused on producing contact lenses. Over the decades, The Cooper Companies has evolved significantly, growing its operations and establishing a presence in more than 100 countries globally.

Business Segments

The Cooper Companies operates primarily through two distinct segments: CooperVision and CooperSurgical.

CooperVision

CooperVision is dedicated to producing a wide array of vision care products, particularly contact lenses. The company is recognized for its innovative advancements in contact lens technology, offering various types of lenses to cater to diverse vision needs. Key product offerings include:

- Soft Contact Lenses: Developed for daily comfort.
- Silicone Hydrogel Lenses: Known for their breathability and moisture retention.
- Toric Lenses: Designed specifically for individuals with astigmatism.
- Multifocal Lenses: Aimed at correcting presbyopia.
- Lens Care Solutions: Products designed to maintain lens hygiene and eye health.

The companys flagship brands include Biofinity, Avaira, Proclear, and Clariti, which are established names in the eyecare industry and noted for their quality and effectiveness in addressing various eye conditions such as myopia and astigmatism.

CooperSurgical

In the fertility sector, CooperSurgical develops and provides medical devices and consumables designed to assist couples in conceiving, particularly through assisted reproductive technologies (ART), including in-vitro fertilization (IVF). The CooperSurgical segment has established itself as a market leader, with a significant presence in key markets such as the United States, Europe, and Japan.

The product range within CooperSurgical includes innovative solutions designed to improve success rates in reproductive health, thereby addressing the increasing global demand for fertility treatments.

Strategic Growth and Acquisitions

The Cooper Companies has a history of strategic acquisitions aimed at enhancing its product portfolio and expanding its market reach. Key acquisitions include:

- In 2014, the company acquired Sauflon Pharmaceuticals, a UK-based manufacturer of contact lenses, bolstering its presence in the European market.
- In 2017, the company acquired the assets of Teva Pharmaceutical?s global women?s health business, significantly broadening its footprint in the women?s health sector and enhancing its offerings in fertility-related products.

Customer Base and Distribution

The Cooper Companies caters to a diversified customer base that includes eye care professionals, hospitals, clinics, and retail outlets. The company also operates an e-commerce platform, allowing patients to purchase contact lenses directly from them and enhancing customer accessibility to their products.

Global Operations

Headquartered in San Ramon, California, The Cooper Companies boasts a robust global infrastructure with manufacturing and distribution facilities strategically located in the United States, Europe, and Asia. As of recent reports, The Cooper Companies employs over 12,000 individuals worldwide, reflecting its commitment to innovation and customer service in the medical device landscape.

Financial Performance

The company has consistently demonstrated strong financial performance, with revenues reflecting its growth and expansion efforts. In FY2020, The Cooper Companies reported revenues of approximately $2.6 billion, underscoring its position as a leading entity in both the ophthalmology and fertility sectors.

Through its focus on innovation, strategic acquisitions, and dedication to serving its diverse global customer base, The Cooper Companies continues to reinforce its status as a vital player in the medical device industry, particularly in vision care and reproductive health.